Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
5m agoFrom Funan to the World Stage, Homegrown mc.2 Acquired by Global Leader Hunter Douglas After Two Decades of Consumer-Led Innovation
6m agoBOE, UNESCO introduce Asia-Pacific Science Club Network & 2026 Science Challenge
38m agoScorpio Tankers Inc. Prices Reopening of 1.75% Convertible Senior Notes due 2031 and Concurrent Stock Repurchase
2h agoAfya Limited Announces First-Quarter 2026 Financial Results
2h agoInnoCare Announces Approval of a Phase II Clinical Trial of TYK2 Inhibitor ICP-488 for Sjögren's Syndrome in China
Yd Bio Limited logo

Yd Bio Limited

About

Yd Bio Limited — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 30 2026
YD Bio Limited Reports Full Year 2025 Financial Results
Mar 31 2026
YD Bio and EG BioMed Jointly Launch Nationwide Telehealth Platform to Accelerate Commercialization of Cancer Detection and Decentralized Clinical Services Across the United States
Mar 17 2026
YD Bio Limited CEO Dr. Ethan Shen Details Strategic Roadmap for Integrated Oncology Ecosystem
Feb 25 2026
YD Bio Limited Announces Strategic Partnership with YC Biotech Co., Ltd. to Establish a Taiwan-U.S. Dual-Core Regulatory Platform
Jan 29 2026
YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy

Community Chat

Ask AI

6ix6ixAIEvents